Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

5

Revenue 2017

Avastin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avastin was produced by Roche.

Roche cites COVID-19 and biosimilars in Q2 decline

Roche cites COVID-19 and biosimilars in Q2 decline

Much of that decline can be attributed to increasing biosimilar competition to three of Roche’s key cancer therapies – Herceptin (trastuzumab), Avastin (bevacizumab) and Rituxan (rituximab).

Tecentriq misses the mark in advanced ovarian cancer

Tecentriq misses the mark in advanced ovarian cancer PD-L1 inhibitor failed to improved progression-free survival. Roche’s Genentech division has reported that Tecentriq, plus Avastin, was unable to improve progression-free survival as a front-line treatment ... The phase 3 IMagyn050 study evaluated the

AZ’s comeback drug cediranib stumbles in phase 3 trial

AZ’s comeback drug cediranib stumbles in phase 3 trial Cediranib has been developed as a potential oral alternative to drugs like Roche’s big-selling injectable VEGF inhibitor Avastin (bevacizumab), which is already used to treat ovarian cancer and other

FDA accepts review to broaden GSK’s Zejula label

FDA accepts review to broaden GSK’s Zejula label Lynparza, like Zejula, has data which backs up its use in ‘all-comer’ ovarian cancer patients – when added to Avastin (bevacizumab), the standard of care for ovarian cancer, the treatment improved ... progression free survival by a median of 22.1

FDA sets June decision date for Tecentriq monotherapy in NSCLC

FDA sets June decision date for Tecentriq monotherapy in NSCLC It is indicated for use in combination with chemotherapy and Roche’s older cancer antibody Avastin (bevacizumab) as a first-line treatment for non-squamous NSCLC.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics